Sage Therapeutics to Present at Upcoming September Investor Conferences

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the following upcoming investor conferences in September:

• Morgan Stanley 21st Annual Global Healthcare Conference (New York, NY): fireside chat on Wednesday, September 13, 2023 at 12:15 p.m. ET.
• TD Cowen 3rd Annual Novel Mechanisms in Neuropsychiatry Summit (Virtual): fireside chat on Wednesday, September 20, 2023 at 3:00 p.m. ET.

A live webcast of each event can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcasts will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230906510555/en/

Investors
Ashley Kaplowitz
786-252-1419
[email protected]

Media Contact
Matthew Henson
917-930-7147
[email protected]

Source: Sage Therapeutics, Inc.

You May Also Be Interested In

• Fujirebio and Sysmex Expand CDMO Partnership into the Field of Neurodegenerative Diseases under Their Immunoassay Collaboration
• ESI Group: PRESS RELEASE OF NOVEMBER 30 2023
• Technip Energies and John Cockerill Reach Closing of Rely, a New Company Dedicated to Integrated Green Hydrogen and Power-to-X Solutions